XML 49 R31.htm IDEA: XBRL DOCUMENT

Insider Trading Arrangements

3 Months Ended

12 Months Ended

Dec. 31, 2023

Our directors and officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted, terminated or modified the Rule 10b5-1 trading arrangements (as defined in Item 408 of Regulation S-K) set forth in the table below. No non-Rule 10b5-1 trading arrangements were adopted, modified or terminated by any director or officer during the period covered by this report.

Name

Title

Type of Trading Arrangement

Security

Action

Date of Action

Duration of Trading Arrangement

Aggregate Number of Securities Covered

Karthikeyan Kuppusamy

SVP, Clinical Solutions

Rule 10b5-1 plan to sell

Common Stock

Adoption

November 16, 2023

November 16, 2023 to November 13, 2024*

Up to 1,760*

Catherine Doherty

SVP, Regional Businesses

Rule 10b5-1 plan to sell

Common Stock

Adoption

August 29, 2023

August 29, 2023 to August 9, 2024*

Up to 8,723*

* Includes shares of common stock to be released from (a) stock options and/or restricted stock units that are expected to vest and/or (b) performance share awards that may vest, subject to the satisfaction of the applicable performance metrics. The actual number of shares of common stock that will be released is not yet determinable and the actual number of shares of common stock that will be sold will be net of the number of shares withheld to satisfy employee tax withholding obligations.

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Karthikeyan Kuppusamy [Member]

Trading Arrangements, by Individual

Name

Karthikeyan Kuppusamy

Title

SVP, Clinical Solutions